BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Integrated DNA Technologies Release: New Approaches to Multiplex qPCR Assays


8/29/2012 10:41:15 AM

CORALVILLE, IA – 29 August 2012 – Integrated DNA Technologies (IDT), the world leader in oligonucleotide synthesis, will be showcasing new approaches to multiplex qPCR assays which offer significant time and cost savings, at Genomics Research Europe, 4th-5th September 2012, Frankfurt, Germany, booth #14. Dr. Scott Rose, Director of Molecular Genetics at IDT, will be presenting a workshop on Multiplexing qPCR PrimeTime Assays with ZEN Dual-Quenched Probes (5th September 2012, 12:45pm – 1:30pm, AqPCR track room) followed by a Technology Spotlight on gBlocks™ Gene Fragments — Sequence-Verified PCR Fragments later that afternoon (3:15pm – 3:30pm).

In the workshop, Dr Rose will present data demonstrating how PrimeTime Predesigned qPCR Assays with ZEN double-quenched probes simplify a 4-plex assay system, saving time and money, and discuss factors that influence the success of using these assays in a multiplex format. The 15 minute technology spotlight will introduce IDT’s new multi-application molecular biology tool, gBlocks™ Gene Fragments. These double-stranded, sequence-verified DNA fragments up to 500 base pairs in length can be used as copy number standards for qPCR, without the need for cloning the endogenous amplicon. Multiple amplicons can be incorporated into a single gBlocks fragment, avoiding the need for linearizing plasmid controls and ensuring that concentrations of the standard dilutions are the same for the individual control assays in the multiplex reaction.

To register to attend Dr Rose’s workshop and learn more about the Technology Spotlight, visit the Genomics Research Europe website for further details. For more information on IDT’s qPCR technologies, please visit www.idtdna.com. Follow us on twitter @idtdna for real-time updates and insights.

About IDT

Integrated DNA Technologies (IDT) is the largest supplier of custom nucleic acids in the United States, serving academic, government, and commercial researchers in biotechnology, clinical diagnostics, and pharmaceutical development. IDT's primary business is the manufacture of custom, synthetic DNA and RNA oligonucleotides. Today, IDT synthesizes and ships an average of 36,000 custom oligos per day to more than 86,000 customers worldwide. IDT manufacturing locations include facilities in Coralville, Iowa; San Diego, Calif.; and Leuven, Belgium. For more information visit www.idtdna.com.

Integrated DNA Technologies

800-328-2661 (US & Canada)

+1 319-626-8400 (outside US)

productinfo@idtdna.com

www.idtdna.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES